share_log

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Foresite Capital Fund IV, L.P. (“FCF IV”)(0.0%),Foresite Capital Management IV, LLC (“FCM IV”)(0.0%), etc.

SEC announcement ·  Feb 13 14:26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more